A First-In-Human Phase 1 Study To Evaluate The Mek1/2 Inhibitor Gdc-0973 Administered Daily In Patients With Advanced Solid Tumors

CANCER RESEARCH(2011)

引用 19|浏览22
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要